1
|
Raghunath K, Sumathi C, Rajappa SJ, Mohan MVTK, Kumar U, Shaik U, Botlagunta M. Impact of naturopathy, yoga, and dietary interventions as adjuvant chemotherapy in the management of stage II and III adenocarcinoma of the colon. Int J Colorectal Dis 2020; 35:2309-2322. [PMID: 32852611 DOI: 10.1007/s00384-020-03711-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/23/2020] [Indexed: 02/04/2023]
Abstract
INTRODUCTION Naturopathy, Yoga and Dietary interventions are known to improve the quality of life in cancer patients. We aim to evaluate the effect of naturopathy interventions along with adjuvant chemotherapy in patients who underwent surgery for Adenocarcinoma of the Colon. METHODS A total of 116 adult patients were randomised in to one of the two groups; the experimental group received naturopathy, Yoga and Dietary interventions and the control group received psycho-social counselling in addition to standard chemotherapy. Haematological, biochemical and psychological evaluations were performed at set intervals during a total period of eighteen months starting from the first cycle of adjuvant chemotherapy. RESULTS Results showed that the overall hemoglobin (p < 0.0001) and carcinoembryonic antigen (CEA) (p = 0.0038) levels were statistically significant in patients on the experimental arm. The rest of the laboratory parameters, viz. total leukocyte count, platelet counts, and serum creatinine levels, for overall data was not statistically significant in both the groups. Psychological attributes such as anxiety, depression, symptom severity, and Functional Living Index: Cancer (FLIC) were found to be statistically significant (p < 0.0001) in the experimental subjects as compared with those in the control. On the whole, men benefited more than women from the study interventions. CONCLUSIONS We conclude that Yoga and Naturopathy interventions in addition to chemotherapy show improvement in overall functional life index along with improvement in haemoglobin in patients with stages II and III Adenocarcinoma of Colon.
Collapse
Affiliation(s)
- Kalpana Raghunath
- Department of Academics, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India.
| | - Ch Sumathi
- Department of Naturopathy and Yoga - Addlife, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India
| | - Senthil J Rajappa
- Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India
| | - M V T Krishna Mohan
- Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India
| | - Uday Kumar
- Department of Naturopathy and Yoga - Addlife, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India
| | - Ummar Shaik
- Indian Institute of Information Technology and Management Kerala, Affiliated to Cochin University, Cochin, India
| | - Mahendran Botlagunta
- Department of Indo American Cancer Research Foundation, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India.
| |
Collapse
|
2
|
Ganaie MA, Jan BL, Khan TH, Alharthy KM, Sheikh IA. The Protective Effect of Naringenin on Oxaliplatin-Induced Genotoxicity in Mice. Chem Pharm Bull (Tokyo) 2019; 67:433-438. [PMID: 30787216 DOI: 10.1248/cpb.c18-00809] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Oxaliplatin is a third generation platinum based anti-cancer drug used against various human malignancies but displays genotoxic properties against normal cells. Naringenin is a naturally occurring bioflavonoid that possesses anti-oxidant properties and has protective effects against DNA damage. The aim of this study is to examine the protective effects of naringenin on oxaliplatin-induced DNA damage in mice. A total of 50, male BALB/c mice were randomly divided equally into five groups. Oxaliplatin toxicity was induced by a single dose (7 mg/kg body weight (b.w.)) injection (intraperitoneally (i.p.)) of oxaliplatin. Naringenin was given orally for ten consecutive days at two doses, 20 mg/kg b.w. (dose I) and 40 mg/kg b.w. (dose II), to group I and group II, respectively. On the tenth day of the experiment, animals in groups III, IV, and V were given a single i.p. injection of oxaliplatin (7 mg/kg b.w.). All the animals were sacrificed 24 h after oxaliplatin treatment. The extent of genotoxicity was assessed by multiple genotoxicity assays (8-hydroxydeoxy-guanosine marker, comet, micronucleus and chromosomal aberration assays, oxidative stress-marker Glutathione evaluation) in order to determine diverse kinds of DNA damage. The results indicated that naringenin administration significantly reduced the DNA damage induced by oxaliplatin possibly due to its strong anti-oxidant properties. The results suggest that naringenin is a potential candidate for future development as a chemoprotective agent against chemotherapy associated complications.
Collapse
Affiliation(s)
- Majid A Ganaie
- Department of Pharmacology, College of Pharmacy, Prince Sattan Bin Abdulaziz University
| | - Basit L Jan
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University
| | - Tajdar H Khan
- Department of Pharmacology, College of Pharmacy, Prince Sattan Bin Abdulaziz University
| | - Khalid M Alharthy
- Department of Pharmacology, College of Pharmacy, Prince Sattan Bin Abdulaziz University
| | - Ishfaq A Sheikh
- King Fahd Medical Research Center, King Abdulaziz University
| |
Collapse
|
3
|
Alqudah MA, Al-Ashwal FY, Alzoubi KH, Alkhatatbeh M, Khabour O. Vitamin E protects human lymphocytes from genotoxicity induced by oxaliplatin. Drug Chem Toxicol 2017; 41:281-286. [DOI: 10.1080/01480545.2017.1384835] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Mohammad A.Y. Alqudah
- Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
| | - Fahmi Y. Al-Ashwal
- Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
| | - Karem H. Alzoubi
- Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
| | - Mohammad Alkhatatbeh
- Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
| | - Omar Khabour
- Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan
| |
Collapse
|
4
|
Chekkat N, Dahm G, Chardon E, Wantz M, Sitz J, Decossas M, Lambert O, Frisch B, Rubbiani R, Gasser G, Guichard G, Fournel S, Bellemin-Laponnaz S. N-Heterocyclic Carbene-Polyethylenimine Platinum Complexes with Potent in Vitro and in Vivo Antitumor Efficacy. Bioconjug Chem 2016; 27:1942-8. [PMID: 27459208 DOI: 10.1021/acs.bioconjchem.6b00320] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The current interest for platinum N-heterocyclic carbene complexes in cancer research stems from their impressive toxicity reported against a range of different human cancer cells. To date, the demonstration of their in vivo efficacy relative to that of established platinum-based drugs has not been specifically addressed. Here, we introduce an innovative approach to increase the NHC-Pt complex potency whereby multiple NHC-Pt(II) complexes are coordinated along a polyethylenimine polymer (PEI) chain. We show that such NHC-Pt(II)-PEI conjugates induce human cancer cell death in vitro and in vivo in a xenograft mouse model with no observable side effects in contrast to oxaliplatin. Additional studies indicate nucleus and mitochondria targeting and suggest various mechanisms of action compared to classical platinum-based anticancer drugs.
Collapse
Affiliation(s)
- Neila Chekkat
- Faculté de Pharmacie, Université de Strasbourg-CNRS UMR 7199 , Route du Rhin, BP 60024, 67401 Illkirch cedex, France
| | - Georges Dahm
- Institut de Physique et Chimie des Matériaux de Strasbourg Université de Strasbourg-CNRS UMR 7504 , 23 rue du Loess, BP 43, 67034 Strasbourg cedex 2, France
| | - Edith Chardon
- Institut de Physique et Chimie des Matériaux de Strasbourg Université de Strasbourg-CNRS UMR 7504 , 23 rue du Loess, BP 43, 67034 Strasbourg cedex 2, France.,Université de Bordeaux, Institut Européen de Chimie et Biologie , 2 rue Robert Escarpit, 33607 Pessac, France.,CNRS, CBMN, UMR 5248 , 33600 Pessac, France
| | - May Wantz
- Faculté de Pharmacie, Université de Strasbourg-CNRS UMR 7199 , Route du Rhin, BP 60024, 67401 Illkirch cedex, France
| | - Justine Sitz
- Faculté de Pharmacie, Université de Strasbourg-CNRS UMR 7199 , Route du Rhin, BP 60024, 67401 Illkirch cedex, France
| | - Marion Decossas
- Université de Bordeaux, Institut Européen de Chimie et Biologie , 2 rue Robert Escarpit, 33607 Pessac, France.,CNRS, CBMN, UMR 5248 , 33600 Pessac, France
| | - Olivier Lambert
- Université de Bordeaux, Institut Européen de Chimie et Biologie , 2 rue Robert Escarpit, 33607 Pessac, France
| | - Benoit Frisch
- Faculté de Pharmacie, Université de Strasbourg-CNRS UMR 7199 , Route du Rhin, BP 60024, 67401 Illkirch cedex, France
| | - Riccardo Rubbiani
- Department of Chemistry, University of Zurich , Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Gilles Gasser
- Department of Chemistry, University of Zurich , Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Gilles Guichard
- Université de Bordeaux, Institut Européen de Chimie et Biologie , 2 rue Robert Escarpit, 33607 Pessac, France.,CNRS, CBMN, UMR 5248 , 33600 Pessac, France
| | - Sylvie Fournel
- Faculté de Pharmacie, Université de Strasbourg-CNRS UMR 7199 , Route du Rhin, BP 60024, 67401 Illkirch cedex, France
| | - Stéphane Bellemin-Laponnaz
- Institut de Physique et Chimie des Matériaux de Strasbourg Université de Strasbourg-CNRS UMR 7504 , 23 rue du Loess, BP 43, 67034 Strasbourg cedex 2, France
| |
Collapse
|
5
|
Mallory CM, Carfi RP, Moon S, Cornell KA, Warner DL. Modification of cellular DNA by synthetic aziridinomitosenes. Bioorg Med Chem 2015; 23:7378-85. [PMID: 26541587 PMCID: PMC4673046 DOI: 10.1016/j.bmc.2015.10.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Revised: 10/13/2015] [Accepted: 10/20/2015] [Indexed: 11/19/2022]
Abstract
Two synthetic aziridinomitosenes (AZMs), Me-AZM and H-AZM, structurally related to mitomycin C (MC) were evaluated for their anticancer activity against six cancer cell lines (HeLa, Jurkat, T47D, HepG2, HL-60, and HuT-78) and tested for their DNA-modifying abilities in Jurkat cells. Cytotoxicity assays showed that Me-AZM is up to 72-fold and 520-fold more potent than MC and H-AZM, respectively. Me-AZM also demonstrated increased DNA modification over MC and H-AZM in alkaline COMET and Hoechst fluorescence assays that measured crosslinks in cellular DNA. Me-AZM and H-AZM treatment of Jurkat cells was found to sponsor significant DNA-protein crosslinks using a K-SDS assay. The results clearly indicate that the AZM C6/C7 substitution pattern plays an important role in drug activity and supports both DNA-DNA and DNA-protein adduct formation as mechanisms for inducing cytotoxic effects.
Collapse
Affiliation(s)
- Chris M Mallory
- Department of Chemistry and Biochemistry, Boise State University, Boise, ID 83725, USA.
| | - Ryan P Carfi
- Department of Chemistry and Biochemistry, Boise State University, Boise, ID 83725, USA.
| | - SangPhil Moon
- Department of Chemistry and Biochemistry, Boise State University, Boise, ID 83725, USA.
| | - Kenneth A Cornell
- Department of Chemistry and Biochemistry, Boise State University, Boise, ID 83725, USA.
| | - Don L Warner
- Department of Chemistry and Biochemistry, Boise State University, Boise, ID 83725, USA.
| |
Collapse
|